Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.17 CHF | +2.13% | +1.56% | +9.78% |
02/06 | Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes | RE |
31/05 | NOVARTIS AG : UBS reiterates its Buy rating | ZD |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- NOVN Stock
- Revisions Novartis AG